Publications by authors named "Utz Krug"

63Publications

Smoking and AML - another piece in the puzzle.

Br J Haematol 2020 Jul 27;190(2):143. Epub 2020 Apr 27.

Department of Medicine A, University Hospital Münster, Münster, Germany.

View Article and Find Full Text PDF
July 2020

Therapy of older persons with acute myeloid leukaemia.

Leuk Res 2017 09 1;60:1-10. Epub 2017 Jun 1.

University Hospital Münster, Department of Medicine A, Albert-Schweitzer-Campus 1, Geb. A1, 48129 Münster, Germany.

View Article and Find Full Text PDF
September 2017

MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.

Exp Hematol 2015 Sep 11;43(9):794-802.e4. Epub 2015 Jun 11.

Department of Medicine A, Hematology, Hemostaseology, Oncology and Pneumology, University of Muenster, Muenster, Germany; Department of Medicine, Hematology and Oncology, University of Halle, Halle, Germany. Electronic address:

View Article and Find Full Text PDF
September 2015

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial.

J Clin Oncol 2015 Feb 29;33(5):403-10. Epub 2014 Dec 29.

Christoph Röllig, Martin Bornhäuser, Michael Kramer, Christian Thiede, Uwe Platzbecker, Martin Wermke, Friedrich Stölzel, Malte von Bonin, Markus Schaich, Johannes Schetelig, and Gerhard Ehninger, Medizinische Klinik und Poliklinik I, Universitätsklinikum der Technischen Universität Dresden; Johannes Schetelig, DKMS, German Bone Marrow Donor Center, Dresden; Anthony D. Ho and Alwin Krämer, Medizinische Universitätsklinik, Abteilung Innere Medizin V, Heidelberg; Kerstin Schäfer-Eckart and Hannes Wandt, 5. Medizinische Klinik, Klinikum Nürnberg, Nürnberg; Mathias Hänel, Klinik für Innere Medizin III, Klinikum Chemnitz, Chemnitz; Hermann Einsele, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg; Walter E. Aulitzky, Robert-Bosch-Krankenhaus, Stuttgart; Norbert Schmitz, Abteilung für Hämatologie, Onkologie und Stammzelltransplantation, ASKLEPIOS Klinik St Georg, Hamburg; Wolfgang E. Berdel, Matthias Stelljes, and Utz Krug, Medizinische Klinik A, Universitätsklinikum Münster, Münster; Carsten Müller-Tidow, Universitätsklinik und Poliklinik für Innere Medizin IV, Universitätsklinikum Halle, Halle (Saale); Claudia D. Baldus, Medizinische Klinik III, Charité-Universitätsmedizin Berlin, Charité Centrum 14, Campus Benjamin Franklin, Berlin; Stefan W. Krause, Medizinische Klinik 5, Universitätsklinikum Erlangen, Erlangen; and Hubert Serve, Medizinische Klinik II, Universitätsklinikum Frankfurt, Frankfurt, Germany.

View Article and Find Full Text PDF
February 2015

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

PLoS One 2014 9;9(10):e109759. Epub 2014 Oct 9.

Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Munich Großhadern, Ludwig-Maximilian-University (LMU), Munich, Germany; Clinical Cooperative Group Pathogenesis of Acute Myeloid Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article and Find Full Text PDF
December 2015

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

J Clin Oncol 2014 May 7;32(15):1586-94. Epub 2014 Apr 7.

Friederike Pastore, Annika Dufour, Tobias Benthaus, Klaus H. Metzeler, Stephanie Schneider, Bianka Ksienzyk, Gudrun Mellert, Evelyn Zellmeier, Purvi M. Kakadia, Michael Unterhalt, Wolfgang Hiddemann, Stefan K. Bohlander, Karsten Spiekermann, and Eva Hoster, University Hospital Munich Großhadern; Friederike Pastore, Klaus H. Metzeler, Wolfgang Hiddemann, Stefan K. Bohlander, and Karsten Spiekermann, Helmholtz Center Munich; Eva Hoster, University of Munich, Munich; Purvi M. Kakadia and Stefan K. Bohlander, University Hospital Marburg, Marburg; Michaela Feuring-Buske, University Hospital Ulm; Christian Buske, Comprehensive Cancer Center Ulm, University of Ulm, Ulm; Jan Braess, Klinikum Barmherzige Brüder, Regensburg; Maria Cristina Sauerland and Achim Heinecke, University of Muenster; Utz Krug, Wolfgang E. Berdel, and Thomas Buechner, University Hospital Muenster, Muenster; Bernhard Woermann, German Society of Hematology and Oncology, Berlin, Germany; Kati S. Maharry, Guido Marcucci, and Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Kati S. Maharry, Mayo Clinic, Rochester, MN; and Stefan K. Bohlander, University of Auckland, Auckland, New Zealand.

View Article and Find Full Text PDF
May 2014

Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.

Br J Haematol 2014 Apr 1;165(1):17-38. Epub 2014 Feb 1.

Department of Haematology and Oncology, Internal Medicine III, Clemenshospital Muenster, Muenster, Germany.

View Article and Find Full Text PDF
April 2014

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.

J Clin Oncol 2014 Feb 23;32(4):288-96. Epub 2013 Dec 23.

Matthias Stelljes, Utz Krug, Maria C. Sauerland, Achim Heinecke, Sandra Ligges, Tim Sauer, Petra Tschanter, Gabriela B. Thoennissen, Björna Berning, Carsten Müller-Tidow, Wolfgang E. Berdel, and Thomas Büchner, University Hospital of Muenster, Muenster; Dietrich W. Beelen, University Hospital of Essen, Essen; Jan Braess, Krankenhaus Barmherzige Brüder; Albrecht Reichle, Ernst Holler, University of Regensburg, Regensburg; Hans J. Kolb, Wolfgang Hiddeman, University of Munich-Grosshadern, Munich; Rainer Schwerdtfeger, Deutsche Klinik für Diagnostik, Wiesbaden; Renate Arnold, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum; Bernhard J. Woermann, German Society of Hematology and Oncology, Berlin; and Christoph Scheid, University of Cologne, Cologne, Germany.

View Article and Find Full Text PDF
February 2014

The treatment of elderly patients with acute myeloid leukemia.

Dtsch Arztebl Int 2011 Dec 26;108(51-52):863-70. Epub 2011 Dec 26.

Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany.

View Article and Find Full Text PDF
December 2011

Maintenance therapy in acute myeloid leukemia revisited: will new agents rekindle an old interest?

Curr Opin Hematol 2010 Mar;17(2):85-90

Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany.

View Article and Find Full Text PDF
March 2010

Clinical image: Lupus erythematosus cells in ascites fluid.

Arthritis Rheum 2009 Mar;60(3):859

University Hospital of Muenster, Muenster, Germany.

View Article and Find Full Text PDF
March 2009

Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.

Int J Oncol 2009 Jan;34(1):129-36

Department of Medicine, Hematology and Oncology, University Hospital of Münster, 48129 Münster, Germany.

View Article and Find Full Text PDF
January 2009

Maintenance for acute myeloid leukemia revisited.

Curr Treat Options Oncol 2007 Aug;8(4):296-304

Department of Medicine, Hematology and Oncology, University of Münster, Albert-Schweitzer-Str. 33, Munster, 48129, Germany.

View Article and Find Full Text PDF
August 2007

New molecular therapy targets in acute myeloid leukemia.

Recent Results Cancer Res 2007 ;176:243-62

Medizinische Klinik A, Universitätsklinikum Münster, Germany.

View Article and Find Full Text PDF
July 2007

Aberrant expression of neutrophil and macrophage-related genes in a murine model for human neutrophil-specific granule deficiency.

J Leukoc Biol 2005 Nov 4;78(5):1153-65. Epub 2005 Oct 4.

Cedars-Sinai Medical Center, Division of Hematology/Oncology, Burns & Allen Research Institute and David Geffen School of Medicine at University of California Los Angeles, USA.

View Article and Find Full Text PDF
November 2005

Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells.

Blood 2004 Jul 16;104(1):237-42. Epub 2004 Mar 16.

Division of Hematology/Oncology, Cedars-Sinai Medical Center, Pediatric Endocrinology, University of California at Los Angeles School of Medicine, USA.

View Article and Find Full Text PDF
July 2004

Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway.

J Biol Chem 2003 Jul 21;278(30):27413-20. Epub 2003 May 21.

Department of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90048, USA.

View Article and Find Full Text PDF
July 2003

Gene expression profile of serial samples of transformed B-cell lymphomas.

Lab Invest 2003 Feb;83(2):271-85

Division of Hematology/Oncology, Department of Pathology and Laboratory Medicine, UCLA School of Medicine, Los Angeles, California 90095, USA.

View Article and Find Full Text PDF
February 2003

Tumor suppressor genes in normal and malignant hematopoiesis.

Oncogene 2002 May;21(21):3475-95

Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California, CA 90048, USA.

View Article and Find Full Text PDF
May 2002

Expression of C/EBPbeta from the C/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo.

Blood 2002 Mar;99(6):2032-6

Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Blvd, Rm. 109, Los Angeles, CA 90048, USA.

View Article and Find Full Text PDF
March 2002

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.

Blood 2002 Feb;99(4):1332-40

Cedars-Sinai Medical Center, Burns and Allen Research Institute, Division of Hematology/Oncology, University of California-Los Angeles School of Medicine, 90048, USA.

View Article and Find Full Text PDF
February 2002

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors.

Genes Chromosomes Cancer 2002 Jan;33(1):17-21

Division of Hematology/Oncology, Department of Medicine, UCLA School of Medicine, Cedars-Sinai Research Institute, 8700 Beverly Blvd., Davis 5019, Los Angeles, CA 90048, USA.

View Article and Find Full Text PDF
January 2002